MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Store in an airtight container and protect from light.

Provenance

This compatibility recommendation is derived from Colofac 135mg tablets (Viatris UK Healthcare Ltd).

Stability Notes

Store in an airtight container and protect from light.

Provenance

This compatibility recommendation is derived from Colofac 135mg tablets (Viatris UK Healthcare Ltd).

Stability Notes

Store in an airtight container and protect from light.

Provenance

This compatibility recommendation is derived from Colofac 135mg tablets (Viatris UK Healthcare Ltd).

Stability Notes

Store in an airtight container and protect from light.

Provenance

This compatibility recommendation is derived from Colofac 135mg tablets (Viatris UK Healthcare Ltd).

Stability Notes

Store in an airtight container and protect from light.

Provenance

This compatibility recommendation is derived from Colofac MR 200mg capsules (Viatris UK Healthcare Ltd).

Stability Notes

Store in an airtight container and protect from light.

Provenance

This compatibility recommendation is derived from Colofac MR 200mg capsules (Viatris UK Healthcare Ltd).

Stability Notes

Protect from light and store in an airtight container.

Provenance

This compatibility recommendation is derived from Combivir 150mg/300mg tablets (ViiV Healthcare UK Ltd).

Stability Notes

Caution in handling by female operatives. Avoid handling leaking capsules. Should not be handled by pregnant women and women of childbearing potential.

Provenance

This compatibility recommendation is derived from Combodart 0.5mg/0.4mg capsules (GlaxoSmithKline UK Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.